Nano-Particle based thermal barriers for the stabilization of proteinaceous and pharmaceuticalcontainers

用于稳定蛋白质和药物容器的纳米颗粒热障

• 批准号: 548660-2019
• 负责人: Rogers, Ben
• 金额: $ 1.82万
• 依托单位: Seneca College of Applied Arts and Technology
• 依托单位国家: 加拿大
• 项目类别: Applied Research and Development Grants - Level 1
• 财政年份: 2019
• 资助国家: 加拿大
• 起止时间: 2019-01-01 至 2020-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=680204
• 关键词: Nano; Particle; based; thermal; barriers

VivaVax is creating new technologies that protect sensitive medicines during transport, and formulations that enhance drug delivery into the body. The World Health Organization estimates that 50% of vaccines are wastedglobally, and up to 70% in developing regions. VivaVax will collaborate with Seneca's School of Biological Science and Applied Chemistry to reduce this number by creating next-generation thermal-barriers for vaccine containers through the development of a novel pore-generation technique within polymer films. Led byProfessor James Mayo and Professor Frank Merante, student Research Assistants (RAs) from Seneca'sBiotechnology Advanced Diploma Program will participate in this project. Improvements developed during thecourse of the project will allow the company to add product lines within its current target market in 2020.Enhancing VivaVax's technology will allow VivaVax to develop two to three new product lines within twoyears of product development.

VivaVax正在开发新技术，以保护运输过程中的敏感药物，以及增强药物输送到体内的配方。世界卫生组织估计，全球50%的疫苗被浪费，在发展中地区高达70%。VivaVax将与Seneca的生物科学和应用化学学院合作，通过开发聚合物薄膜内的新型孔生成技术，为疫苗容器创造下一代热障，从而减少这一数字。在James马约教授和Frank Merante教授的带领下，Seneca生物技术高级文凭课程的学生研究助理（RA）将参与该项目。在项目过程中开发的改进将使公司能够在2020年在其当前目标市场中增加产品线。增强VivaVax的技术将使VivaVax能够在产品开发的两年内开发两到三条新产品线。